000 01367 a2200373 4500
005 20250512195334.0
264 0 _c19811014
008 198110s 0 0 eng d
022 _a0024-3205
024 7 _a10.1016/0024-3205(81)90171-5
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDaiguji, M
245 0 0 _aHuman platelet alpha 2-adrenergic receptors: labeling with 3H-yohimbine, a selective antagonist ligand.
_h[electronic resource]
260 _bLife sciences
_cJun 1981
300 _a2705-17 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAdrenergic alpha-Antagonists
_xpharmacology
650 0 4 _aBlood Platelets
_xmetabolism
650 0 4 _aCatecholamines
_xpharmacology
650 0 4 _aDihydroergotoxine
_xmetabolism
650 0 4 _aDioxanes
_xmetabolism
650 0 4 _aHumans
650 0 4 _aImidazoles
_xpharmacology
650 0 4 _aKinetics
650 0 4 _aMagnesium
_xpharmacology
650 0 4 _aPrazosin
_xmetabolism
650 0 4 _aReceptors, Adrenergic
_xmetabolism
650 0 4 _aReceptors, Adrenergic, alpha
_xdrug effects
650 0 4 _aYohimbine
_xmetabolism
700 1 _aMeltzer, H Y
700 1 _aU'Prichard, D C
773 0 _tLife sciences
_gvol. 28
_gno. 24
_gp. 2705-17
856 4 0 _uhttps://doi.org/10.1016/0024-3205(81)90171-5
_zAvailable from publisher's website
999 _c6115385
_d6115385